Global Peptide Cancer Vaccine Market Research Report 2018

This report studies the Peptide Cancer Vaccine market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Peptide Cancer Vaccine market by product type and applications/end industries.

The major players in global Peptide Cancer Vaccine market include
TapImmune
BrightPath Biotherapeutics
Ultimovacs
Sellas
Boston Biomedical
Imugene
VAXON Biotech
Generex Biotechnology
ISA Pharmaceuticals
OncoTherapy Science
Immatics

Geographically, this report is segmented into several key Regions, with revenue, market share and growth rate of Peptide Cancer Vaccine in these regions, from 2012 to 2023 (forecast), covering
USA
Europe
China
Japan
South America
RoW

On the basis on the end users/applications, this report covers
Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Others

Table of Contents

1 Peptide Cancer Vaccine Market Overview 1
1.1 Peptide Cancer Vaccine Product Overview 1
1.2 Peptide Vaccine Strategies in the Treatment of Cancer 1
1.3 Global Peptide Cancer Vaccine Segment by Applications 4
1.3.1 Global Peptide Cancer Vaccine Revenue Market Share by Applications in 2025 4
1.3.2 Breast Cancer 4
1.3.3 Lung Cancer 5
1.3.4 Melanoma 6
1.3.5 Prostate Cancer 7
1.4 Global Peptide Cancer Vaccine Market by Regions (2020-2030) 8
1.4.1 Global Peptide Cancer Vaccine Market Size and Growth Rate Comparison by Regions (2020-2030) 8
1.4.2 USA Peptide Cancer Vaccine Status and Prospect (2020-2030) 9
1.4.3 Europe Peptide Cancer Vaccine Status and Prospect (2020-2030) 10
1.4.4 Japan Peptide Cancer Vaccine Status and Prospect (2020-2030) 11
1.5 Global Peptide Cancer Vaccine Market Size (2020-2030) 12
1.6 Global Manufacturers Peptide Cancer Vaccine Headquarters, Established and Product 12
2 Cancer Vaccines and Immunotherapy 14
2.1 Therapeutic Vaccines 14
2.1.1 Autologous Cancer Vaccines 15
2.1.2 Allogenic Cancer Vaccines 16
2.1.3 Protein or Peptide Cancer Vaccines 16
2.1.4 DNA Vaccines 16
2.2 Other Approaches 16
2.3 Clinical Considerations for Therapeutic Cancer Vaccines 17
2.3.1 Considerations for both Early and Late Phase Clinical Trials 18
2.3.2 Considerations for Early Phase Clinical Trials 18
2.3.3 Considerations for Late Phase Clinical Trials 19
3 Wide Spectrum Action of Peptide Cancer Vaccines against Major Cancer 20
3.1 Peptides & Colorectal Cancer 20
3.1.1 Colorectal Cancer Introduction 20
3.1.2 Introduction of the Number of Patients with Colorectal Cancer 20
3.1.3 Peptide Cancer Vaccine Introduction about Colorectal Cancer 21
3.2 Peptides & Lung Cancer 22
3.2.1 Lung Cancer Introduction 22
3.2.2 Introduction of the Number of Patients with Lung Cancer 23
3.2.3 Peptide Cancer Vaccine Introduction about Lung Cancer 25
3.3 Peptides & Pancreatic Cancer 26
3.3.1 Pancreatic Cancer Introduction 26
3.3.2 Introduction of the Number of Patients with Pancreatic Cancer 27
3.3.3 Peptide Cancer Vaccine Introduction about Pancreatic Cancer 28
3.4 Peptides & Breast Cancer 29
3.4.1 Breast Cancer Introduction 29
3.4.2 Introduction of the Number of Patients with Breast Cancer 29
3.4.3 Peptide Cancer Vaccine Introduction about Breast Cancer 30
3.5 Peptides & Prostate Cancer 31
3.5.1 Prostate Cancer Introduction 31
3.5.2 Introduction of the Number of Patients with Prostate Cancer 32
3.5.3 Peptide Cancer Vaccine Introduction about Prostate Cancer 33
3.6 Peptides & Other Cancer 34
4 Global Peptide Cancer Vaccine by Pipeline 37
4.1 ITK-1 37
4.2 GRN-1201 38
4.3 TPIV200 40
4.4 TPIV110 40
4.5 UV1 41
4.6 galinpepimut-S 42
4.7 TARP 27-35 42
4.8 HER-Vaxx 43
4.9 Vx-001 45
4.10 Vx-006 46
4.11 Vx-016 46
4.12 AE37 47
4.13 ISA101 (HPV) 49
4.14 MyISA (Personalized immunotherapy based on neoantigens) 50
4.15 ISA203 (PRAME) 51
4.16 ISA204 (HBV) 51
4.17 OTSA101 52
4.18 GALINPEPIMUT-S AND KEYTRUDA (PEMBROLIZUMAB) 53
4.19 ACTolog 54
4.20 DSP-7888 Dosing Emulsion plus Bevacizumab 55
4.21 DSP-7888 in Patients with Myelodysplastic Syndrome (MDS) 55
4.22 DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas 56
4.23 DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies 56
5 Global Cancer Vaccine Consumption by Regions (2012-2017) 57
5.1 Global Cancer Vaccine Consumption by Regions (2012-2017) 57
5.2 North America Cancer Vaccine Consumption (2012-2017) 61
5.3 Europe Cancer Vaccine Consumption (2012-2017) 63
5.4 China Cancer Vaccine Consumption (2012-2017) 65
5.5 Japan Cancer Vaccine Consumption (2012-2017) 67
6 Cancer Vaccine Market Size Analysis by Main Players 2012-2017 69
6.1 Global Cancer Vaccine Sales and Share by Manufacturers (2012-2017) 69
6.2 Global Cancer Vaccine Revenue and Share by Manufacturers (2012-2017) 71
6.3 Vaccine Market Size Analysis by Main Players 72
6.3.1 Merck 72
6.3.2 GSK 77
6.3.3 Dendreon 80
7 Analysis of Peptide Cancer Vaccine Industry Key Manufacturers 84
7.1 Boston Biomedical 84
7.1.1 Company Profile 84
7.1.2 Product Information 85
7.2 Ultimovacs 85
7.2.1 Company Profile 85
7.2.2 Product Information 86
7.3 BrightPath Biotherapeutics 88
7.3.1 Company Profile 88
7.3.2 Product Information 90
7.4 TapImmune 92
7.4.1 Company Profile 92
7.4.2 Product Information 94
7.5 Immatics 95
7.5.1 Company Profile 95
7.5.2 Product Information 96
7.6 Sellas 97
7.6.1 Company Profile 97
7.6.2 Product Information 98
7.7 Imugene 99
7.7.1 Company Profile 99
7.7.2 Product Information 100
7.8 VAXON Biotech 100
7.8.1 Company Profile 100
7.8.2 Product Information 102
7.9 Generex Biotechnology 102
7.9.1 Company Profile 102
7.9.2 Product Information 104
7.10 ISA Pharmaceuticals 104
7.10.1 Company Profile 104
7.10.2 Product Information 105
7.11 OncoTherapy Science 106
7.11.1 Company Profile 106
7.11.2 Product Information 108
8 Peptide Cancer Vaccine Manufacturing Cost Analysis 110
8.1 Peptide Cancer Vaccine R&D Cost Analysis 110
8.1.1 Clinical Phase Costs 111
8.1.2 Capitalized Costs 112
8.2 Proportion of Manufacturing Cost Structure 113
8.2.1 Raw Materials 113
8.2.2 Labor Cost 114
8.2.3 Other Costs Analysis 120
8.3 Manufacturing Process Analysis of Peptide Cancer Vaccine 125
9 Industrial Chain, Sourcing Strategy and Downstream Buyers 128
9.1 Peptide Cancer Vaccine Peptide Cancer Vaccine Discovery and Development Analysis 128
9.2 Upstream Raw Materials Sourcing 129
9.3 Downstream Buyers 130
10 Marketing Strategy Analysis 132
10.1 Marketing Channel 132
10.1.1 Direct Marketing 132
10.1.2 Indirect Marketing 132
10.1.3 Marketing Channel Development Trend 132
10.2 Market Positioning 133
10.2.1 Pricing Strategy 133
10.2.2 Brand Strategy 135
11 Market Effect Factors Analysis 137
11.1 Technology Progress in Related Industry 137
11.2 Consumer Needs/Customer Preference Change 138
11.3 Economic/Political Environmental Change 139
12 Global Peptide Cancer Vaccine Market Forecast (2020-2030) 149
12.1 Global Peptide Cancer Vaccine Revenue Forecast (2020-2030) 149
12.2 Global Peptide Cancer Vaccine Revenue Forecast by Regions (2020-2030) 149
12.3 Global Peptide Cancer Vaccine Consumption Forecast by Regions (2020-2030) 152
12.3.1 USA Peptide Cancer Vaccine Consumption Forecast (2020-2030) 155
12.3.2 Europe Peptide Cancer Vaccine Consumption Forecast (2020-2030) 156
12.3.3 China Peptide Cancer Vaccine Consumption Forecast (2020-2030) 157
12.3.4 Japan Peptide Cancer Vaccine Consumption Forecast (2020-2030) 158
12.3.5 South America Peptide Cancer Vaccine Consumption Forecast (2020-2030) 159
12.4 Global Peptide Cancer Vaccine Consumption Forecast by Application (2020-2030) 159
13 Research Findings and Conclusion 162
14 Methodology and Data Source 163
14.1 Methodology/Research Approach 163
14.1.1 Research Programs/Design 163
14.1.2 Market Size Estimation 164
14.1.3 Market Breakdown and Data Triangulation 165
14.2 Data Source 166
14.2.1 Secondary Sources 166
14.2.2 Primary Sources 167
14.3 Disclaimer 168
14.4 Author List 170




List of Tables and Figures

Figure Product Picture of Peptide Cancer Vaccine 1
Figure Global Peptide Cancer Vaccine Revenue Market Share by Applications in 2025 4
Figure Breast Cancer Examples 5
Figure Lung Cancer Examples 6
Figure Melanoma Examples 7
Figure Prostate Cancer Examples 7
Table Peptide Cancer Vaccine Market Size (M USD) Comparison by Regions (2020-2030) 8
Figure USA Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030) 9
Figure Europe Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030) 10
Figure Japan Peptide Cancer Vaccine Revenue (M USD) and Growth Rate (2020-2030) 11
Figure Global Peptide Cancer Vaccine Revenue (M USD) Status and Outlook (2020-2030) 12
Table Global Players/Manufacturers Peptide Cancer Vaccine Headquarters and Established 12
Table Global Manufacturers Peptide Cancer Vaccine Product 13
Top 20 Countries Highest Incidence of Colorectal Cancer in 2016 21
Top 20 Countries Highest Incidence of Lung Cancer in 2016 23
Figure Percent of New Cases by Age Group: Lung Cancer 24
Figure Percent of Deaths by Age Group: Lung Cancer 24
Table Active Immunotherapies in Phase III Development 25
Top 20 Countries Highest Incidence of Pancreatic Cancer in 2016 27
Table Active Immunotherapies in Phase III Development 28
Top 20 Countries Highest Incidence of Breast Cancer in 2016 30
Table Active Immunotherapies in Phase III Development 31
Figure Percent of New Cases by Age Group: Prostate Cancer 32
Figure Percent of Deaths by Age Group: Prostate Cancer 33
Figure Estimated Prostate Cancer Incidence Worldwide in 2016 33
Information about World Cancer Statistics for the Most Common Cancers (excluding non-melanoma Skin Cancer) in 2016 35
Table Active Immunotherapies in Phase III Development 35
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 37
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 38
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 39
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 39
Figure UV1 Technology 41
Figure How HER-Vaxx is Tntended to Work 45
Figure Molecular Modeling Study-MHC Class II Receptor 48
Figure Li Suppression 48
Figure Li-KEY Hybrid 49
Figure Antitumor Activity of OTSA101 53
Figure Peptide Cancer Vaccine Product Information of Sellas 53
Figure Peptide Cancer Vaccine Product Information of Immatics 54
Figure Peptide Cancer Vaccine Product Information of Boston Biomedical 55
Figure Peptide Cancer Vaccine Product Information of Sumitomo Dainippon 55
Figure Peptide Cancer Vaccine Product Information of Sumitomo Dainippon 56
Figure Peptide Cancer Vaccine Product Information of Boston Biomedical 56
Table Global Cancer Vaccine Consumption (K Doses) Market by Regions (2012-2017) 57
Table Global Cancer Vaccine Consumption Market Share by Regions (2012-2017) 57
Figure Global Cancer Vaccine Consumption Market Share by Regions (2012-2017) 58
Figure 2017 Global Cancer Vaccine Consumption Market Share by Regions 58
Table Global Cancer Vaccine Revenue (M USD) Market by Regions (2012-2017) 59
Table Global Cancer Vaccine Revenue Market Share by Regions (2012-2017) 59
Figure Global Cancer Vaccine Revenue Market Share by Regions (2012-2017) 59
Figure 2017 Global Cancer Vaccine Revenue Market Share by Regions 60
Figure North America Cancer Vaccine Consumption (K Doses) and Growth Rate (2012-2017) 61
Figure North America Cancer Vaccine Revenue (M USD) and Growth Rate (2012-2017) 62
Figure Europe Cancer Vaccine Consumption (K Doses) and Growth Rate (2012-2017) 63
Figure Europe Cancer Vaccine Revenue (M USD) and Growth Rate (2012-2017) 64
Figure China Cancer Vaccine Consumption (K Doses) and Growth Rate (2012-2017) 65
Figure China Cancer Vaccine Revenue (M USD) and Growth Rate (2012-2017) 66
Figure Japan Cancer Vaccine Consumption (K Doses) and Growth Rate (2012-2017) 67
Figure Japan Cancer Vaccine Revenue (M USD) and Growth Rate (2012-2017) 68
Table Global Cancer Vaccine Sales (K Doses) of Key Manufacturers (2012-2017) 69
Table Global Cancer Vaccine Sales Market Share by Manufacturers (2012-2017) 69
Figure 2012 Cancer Vaccine Sales Market Share by Manufacturers 70
Figure 2017 Cancer Vaccine Sales Market Share by Manufacturers 70
Table Global Cancer Vaccine Revenue (M USD) by Manufacturers (2012-2017) 71
Table Global Cancer Vaccine Revenue Share by Manufacturers (2012-2017) 71
Figure 2012 Global Cancer Vaccine Revenue Share by Manufacturers 71
Figure 2017 Global Cancer Vaccine Revenue Share by Manufacturers 72
Table Merck Company Profile 72
Table Cancer Vaccine Product Information of Merck 74
Table Cancer Vaccine Sales (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2012-2017 75
Figure Cancer Vaccine Sales (K Doses) and Growth Rate of Merck 2012-2017 76
Figure Cancer Vaccine Revenue (M USD) and Global Market Share of Merck 2012-2017 77
Table GSK Company Profile 77
Table Cancer Vaccine Product Information of GSK 78
Table Cancer Vaccine Sales (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GSK 2012-2017 79
Figure Cancer Vaccine Sales (K Doses) and Growth Rate of GSK 2012-2017 79
Figure Cancer Vaccine Revenue (M USD) and Global Market Share of GSK 2012-2017 80
Table Dendreon Company Profile 80
Table Cancer Vaccine Product Information of Dendreon 81
Table Cancer Vaccine Sales (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Dendreon 2012-2017 82
Figure Cancer Vaccine Sales (K Doses) and Growth Rate of Dendreon 2012-2017 82
Figure Cancer Vaccine Revenue (M USD) and Global Market Share of Dendreon 2012-2017 83
Table Boston Biomedical Company Profile 84
Figure Peptide Cancer Vaccine Product Information of Boston Biomedical 85
Table Ultimovacs Company Profile 85
Table Peptide Cancer Vaccine Product Picture and Specifications of Ultimovacs 86
Table BrightPath Biotherapeutics Company Profile 88
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 90
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 91
Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 92
Table TapImmune Company Profile 92
Figure Peptide Cancer Vaccine Product Picture and Specifications of TapImmune 94
Table Immatics Company Profile 95
Figure Peptide Cancer Vaccine Product Information of Immatics 96
Table Sellas Company Profile 97
Figure Peptide Cancer Vaccine Product Information of Sellas 98
Table Imugene Company Profile 99
Figure Peptide Cancer Vaccine Product Picture of Imugene 100
Table VAXON Biotech Company Profile 100
Figure Peptide Cancer Vaccine Product Picture of VAXON Biotech 102
Table Generex Biotechnology Company Profile 102
Figure Peptide Cancer Vaccine Product Picture of Generex Biotechnology 104
Table ISA Pharmaceuticals Company Profile 104
Table OncoTherapy Science Company Profile 106
Figure Peptide Cancer Vaccine Product Picture of OncoTherapy Science 108
Figure Typical Phases from Research to the Market for a Cancer Vaccine Candidate 111
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound 112
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 113
Figure Manufacturing Cost Structure of Peptide Cancer Vaccine 113
Figure USA Overview of Average Hourly Wages 2016-2017 (USD/Hour) 114
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points) 115
Figure Cost of Employing a Factory Worker 116
Figure 2016 Estimated Labor Costs for the Whole Economy in Europe 117
Figure Monthly Minimum Wages in Asia 2016 118
Figure China Overview of Average Yearly Wages 2016-2017 (CNY/Year) 119
Figure Japan Overview of Average Monthly Wages 2016-2017 (JPY Thousand/Month) 119
Table Average Price of Electricity to Ultimate Customers 120
Figure Electricity Prices for Household Consumers in 2016 121
Figure Summary of the Driving Assumptions 122
Figure Industrial Electric Rates 2016 (PER KWH) 123
Figure Anti-cancer Process 125
Figure Manufacturing Process Analysis of Peptide Cancer Vaccine 126
Figure Roadmap to the Development of Predictive Biomarkers for Active Immunotherapy 127
Figure Peptide Cancer Vaccine Discovery and Development 128
Table Major Buyers of Peptide Cancer Vaccine 130
Figure Setting Pricing Policy 134
Figure Global GDP Growth Rate for 2016 140
Figure Real GDP Growth 2016-2020 annual Average 141
Figure US GDP 2006-2016 (Billion USD) 142
Figure US CPI Change 2016-2017 142
Figure EU GDP 2006-2016 (Billion USD) 143
Figure EU CPI Change 2012-2016 143
Figure Germany GDP 2006-2016 (Billion USD) 144
Figure Germany CPI Change 2016-2017 144
Figure UK GDP 2006-2016 (Billion USD) 145
Figure UK CPI Change 2016-2017 145
Figure Italy GDP 2006-2016 (Billion USD) 146
Figure Italy CPI Change 2016-2017 146
Figure Japan GDP 2006-2016 (Billion USD) 147
Figure Japan CPI Change 2012-2016 147
Figure China GDP 2006-2016 (Billion USD) 148
Figure China CPI Change 2016-2017 148
Figure Global Peptide Cancer Vaccine Revenue (M USD) and Growth Rate Forecast (2020-2030) 149
Table Global Peptide Cancer Vaccine Revenue (M USD) Forecast by Regions (2020-2025) 149
Table Global Peptide Cancer Vaccine Revenue (M USD) Forecast by Regions (2025-2030) 150
Table Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions (2020-2025) 150
Table Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions (2025-2030) 150
Figure Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions (2020-2030) 151
Figure Global Peptide Cancer Vaccine Revenue Market Share Forecast by Regions in 2025 151
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Regions (2020-2025) 152
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Regions (2025-2030) 152
Table Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions (2020-2025) 152
Table Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions (2025-2030) 153
Figure Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions (2020-2030) 153
Figure Global Peptide Cancer Vaccine Consumption Market Share Forecast by Regions in 2025 154
Figure USA Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 155
Figure Europe Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 156
Figure China Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 157
Figure Japan Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 158
Figure South America Peptide Cancer Vaccine Consumption (M USD) and Growth Rate Forecast (2020-2030) 159
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Application (2020-2025) 159
Table Global Peptide Cancer Vaccine Consumption (M USD) Forecast by Application (2025-2030) 160
Table Global Peptide Cancer Vaccine Consumption Forecast by Application (2020-2025) 160
Table Global Peptide Cancer Vaccine Consumption Forecast by Application (2025-2030) 160
Figure Global Peptide Cancer Vaccine Consumption Forecast by Application (2020-2030) 161
Figure Global Peptide Cancer Vaccine Consumption Forecast by Application in 2025 161
Table Research Programs/Design for This Report 163
Figure Bottom-up and Top-down Approaches for This Report 165
Figure Data Triangulation 166
Table Key Data Information from Secondary Sources 167
Table Key Data Information from Primary Sources 168

Global Prostate Cancer Diagnostics Market Professional Survey Report 2017

Published Date : Sep 2017

This report studies Prostate Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top m...

Asia-Pacific Vaccine Conjugate Market Report 2017

Published Date : Sep 2017

In this report, the Asia-Pacific Vaccine Conjugate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (...

Asia-Pacific Marine Collagen Peptide Market Report 2017

Published Date : Sep 2017

In this report, the Asia-Pacific Marine Collagen Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with s...

Asia-Pacific Marine Bone Collagen Peptide Powder Market Report 2017

Published Date : Sep 2017

In this report, the Asia-Pacific Marine Bone Collagen Peptide Powder market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Reg...

Global Tofu Machines Market Research Report 2017

Published Date : Sep 2017

In this report, the global Tofu Machines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption...

Global Supercapacitor Materials Market Research Report 2017

Published Date : Sep 2017

In this report, the global Supercapacitor Materials market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, ...

Global Silicon Carbide for Semiconductor Market Research Report 2017

Published Date : Sep 2017

In this report, the global Silicon Carbide for Semiconductor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with pro...

Global Shiitake Extracts Market Research Report 2017

Published Date : Sep 2017

In this report, the global Shiitake Extracts market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consump...

Global Protein Fractionation Market Research Report 2017

Published Date : Sep 2017

In this report, the global Protein Fractionation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, con...

Global Precision Food Thermometers Market Research Report 2017

Published Date : Sep 2017

In this report, the global Precision Food Thermometers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with productio...

 

Select Licence :

  • Single User : $2900
  • Corporate User : $5800

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.